Scenario & Background A mid-sized biotech company developing a novel oncology cell therapy was running multiple Phase II trials across different sites. The company’s internal safety team was overwhelmed by the volume of adverse event (AE) reports and needed support in: However, the client did not want a new IT platform or continuous system integration.
Client: Mid-sized biotech company developing novel biologics.Industry: Biotechnology / Life SciencesPositions: 2 QA Specialists and 3 Validation Engineers Background A biotech company was advancing a promising therapeutic candidate through clinical studies toward commercialization. To meet FDA submission timelines, validation of their GMP manufacturing and QC lab equipment and systems had to be completed within six
In the biotech industry, the integrity of documentation is just as critical as the product itself. Master Batch Records (MBRs) guide the execution of production steps, while Standard Operating Procedures (SOPs) define how those steps should be performed and documented. These two document types are deeply interconnected, and any misalignment between them can lead to
As part of preparing for commercial readiness, a Phase 3 biotech client faced a pivotal challenge: expanding into the European Union while meeting critical regulatory filing and inspection requirements. Their internal regulatory team was well-versed in U.S. requirements but lacked specific expertise in EU Module 3 expectations, centralized procedures, and regional submission strategy. The challenge:
Scenario: A Biotech Company Analyzing 500+ Deviations to Uncover Trends and Gain Cross-Departmental Clarity A mid-sized biotech company had over 500 deviations logged at a single manufacturing site, spread across multiple departments including Quality, Manufacturing, Engineering, and Supply Chain. The data resided in their existing systems (QMS, Excel exports, reports), and they saw an opportunity
Whether you’re running a biologics manufacturing plant, managing clinical trial data, or operating a quality management system, your computerized systems play a critical role in ensuring product quality and patient safety. But systems age, users change, processes evolve—and what worked flawlessly two years ago might be a compliance risk today. That’s where periodic reviews come
As biotech companies scale from clinical to commercial manufacturing, expansion of GMP facilities brings both exciting growth opportunities and complex regulatory challenges. One area that demands foresight is Computer System Validation (CSV) — the process of ensuring that software systems used in GMP environments are functioning as intended and in compliance with regulations such as
Setting up a GMP-compliant manufacturing site is one of the most critical steps for a biotech company transitioning into clinical or commercial production. In today’s digital landscape, implementing robust Computer System Validation (CSV) practices from the outset is essential—not only to meet regulatory expectations but to ensure seamless, reliable, and compliant operations across your production
As biotech companies move into clinical trials or commercial readiness, their Quality Control (QC) labs must scale quickly to support expanding operations. But scaling a QC lab isn’t just about acquiring more instruments or running more tests. It’s about validating smarter. Computer System Validation (CSV) becomes increasingly important—and complex—as companies prepare for INDs, BLAs, or
Launching a biotech company is an exciting journey, especially when it’s time to build your first GMP-compliant Quality Control (QC) lab. Amid the rush to select instruments, hire scientists, and finalize test methods, one foundational piece often gets overlooked—Computer System Validation (CSV). Whether you’re preparing for your first IND or simply trying to get your